Press release
Notified Bodies discuss their changing role within the IVD industry this June in London
SMi Group’s 3rd In Vitro Diagnostics conference will take place in London on the 14th & 15th June 2017.With the final text for the new IVDR due this spring and the regulatory changes within the IVD industry fast approaching, people working within the field need to be informed with all the relevant information on how this will affect their organisation and how they carry out their business. SMi's 3rd In Vitro Diagnostics show will explore the complex and ever-changing landscapes of IVDs and focus on informative regulatory updates and providing feedback from leading IVD manufacturers.
The 2017 event will provide attendees with 16 presentations from industry experts, a panel discussion, 5+ hours of networking time and a pre-conference workshop on implementing an EU-IVDR compliance program.
A key highlight of the show will be the open panel discussion on day one of the event on 'The Changing Role of Notified Bodies'. This panel will bring together the participating Notified Bodies to allow attendees to direct any questions they have to the expert panel of notified body representatives. The representatives will also discuss: How to prepare for unannounced audits; how to organise reviews with your Notified Body and how to manage the increase in scrutiny on technical files – ensuring your files are up to your Notified Bodies standard.
Participants include:
Sue Spencer, Head of Global Medical Device Services, UL International
Nick Baker, Technical Manager-IVD, LRQA
Dieter Schoenwald, IVD Manager, TUV SUD
Erica Conway, Global Head - IVD, BSI
Julien Senac, Certification Project Manager, LNE/G-MED
Other speakers presenting at this year’s conference include FDA, MHRA, Johnson & Johnson, DEKRA, Berlin Heart GmbH and many more…
A full speaker line-up and detailed conference agenda is available to download online at www.in-vitro-diagnostics.co.uk/openpr For those looking to attend, there is currently a £300 discount available which expires on 31st March 2017.
In Vitro Diagnostics
14th & 15th June 2017
London, UK
Sponsored by Qarad
www.in-vitro-diagnostics.co.uk/openpr
Contact Information:
For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: zgale@smi-online.co.uk
To register for the conference, visit www.in-vitro-diagnostics.co.uk/openpr or contact Adolis Miniauskas on +44 (0) 20 7827 6744 / aminiauskas@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk
---END---
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Ground & First Floor
1 Westminster Bridge Road
London, SE1 7XW
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Notified Bodies discuss their changing role within the IVD industry this June in London here
News-ID: 476323 • Views: …
More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…

Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…

FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for IVD
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysing…
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of…
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The IVD research report also provides insights of different regions that are contributing market growth.…
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688
The report provides a…
Infectious Disease IVD Market – Forecast to 2026
The findings reviewed by GME stated that the Global Infectious Disease In-Vitro Diagnostics Market would grow at a CAGR value of 4.6 percent from 2021 to 2026. The increasing geriatric population is the primary driving factor for the infectious disease in-vitro diagnostics market. Besides, the increasing number of infectious diseases, launch of advanced testing kits and beneficial features attributed by IVDs are propelling growth in the market.
Browse 159 Market…
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256
The Asia-Pacific IVD market is…